Filter
381
Text search:
virus
variants
Featured
Recommendations
69
New Publications
26
Language
Document type
Guidelines
115
Studies & Reports
80
No document type
59
Fact sheets
46
Strategic & Response Plan
31
Manuals
23
Training Material
8
Videos
8
Resource Platforms
5
Situation Updates
3
Brochures
2
Infographics
1
Countries / Regions
Global
23
Latin America and the Carribbean
16
Africa
13
India
9
Western and Central Europe
8
Germany
7
Kenya
7
Brazil
7
South Africa
5
East and Southern Africa
5
West and Central Africa
5
Nigeria
4
Niger
4
Malawi
4
Middle East and North Africa
4
Russia
4
Senegal
3
Congo, Democratic Republic of
3
Ethiopia
3
Cameroon
3
South Sudan
3
South–East Asia Region
3
Eastern Europe
3
Spain
3
Burkina Faso
2
Liberia
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Uganda
2
Haiti
2
Lebanon
2
Turkey
2
Syria
2
Chad
2
Rwanda
2
Mozambique
2
Sudan
2
Peru
2
Bolivia
2
Chile
2
Asia
2
France
2
Tunisia
2
Guinea
1
Sierra Leone
1
Saudi Arabia
1
Ghana
1
Zimbabwe
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Egypt
1
Mauritania
1
Benin
1
Argentina
1
Dominican Republic
1
Eswatini/ Swaziland
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Yemen
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Venezuela
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Gabon
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
95
Clinical Guidelines
31
Public Health
16
Key Resources
14
Pharmacy & Technologies
12
Women & Child Health
7
Capacity Building
3
Toolboxes
COVID-19
218
HIV
22
Rapid Response
19
Planetary Health
11
NTDs
11
2.0 Rapid Response
9
TB
8
Ebola & Marburg
7
Health Financing Toolbox
7
AMR
6
Global Health Education
5
Mental Health
4
NCDs
4
Malaria
4
Caregiver
3
Refugee
2
Pharmacy
2
Cholera
1
Polio
1
Conflict
1
Zika
1
Specific Hazards
1
This guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-
...
14 July 2021 This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
COVID-19 vaccines have proven to be safe,
...
The number of COVID-19 cases is on the rise again, with South Africa nearing half of all confirmed cases in the WHO African Region. Threats of new variants loom and low vaccination coverage raises questions on the future of the response to COVID-19.
...
Every country has been affected by COVID-19, with nearly a quarter
of a billion cases and almost 5 million deaths reported globally as of
end of September 2021. Despite the stunning speed with which highly
effective and safe vaccines have been developed, new waves of disease
are still pushin
...
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants w
...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus
...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We
...
Le nombre de cas de COVID-19 augmente à nouveau, l’Afrique du Sud comptant pour près de la moitié de tous les cas confirmés de la Région africaine de l’OMS. La menace de nouveaux variants plane, et la faible couverture vaccinale soulève de
...
There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for
...
Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory
...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s
...
This new plan has been developed to build on successes made and lessons learnt from implementation of the two initial plans and to provide a short to medium term strategic anchor against which preparedness and response plans to the corona virus dise
...
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of
...
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises.
It remains critical for national programmes to continue to offer testing for COVI
...
Les pays du monde entier sont confrontés à des situations épidémiologiques diverses, et disposent de capacités de réaction différentes et d’un accès inégal aux outils permettant de sauver des vies. L’Organisation mondiale de la Santé (OMS) recommande aux autorités nationales de contin
...
Cervical cancer is the fourth most common cancer in women worldwide in 2018, with 570,000 new cases and 311,000 deaths occurring annually.T he highest incidence rates are in Southern Africa, Eastern Africa, SubSaharan Africa, Western Africa, Melanesia, and Middle Africa . It also ranks as the leadin
...
While much progress has been achieved over the past year, the Region of the Americas has stubbornly remained the epicenter of the COVID-19 pandemic. PAHO is launching its 2021 COVID-19 Response Strategy and Donor Appeal to continue supporting Latin American and Caribbean countries and territories i
...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant]
...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr
...
